Bladder & Bowel Institute is the world's leading provider of advanced therapy for bladder and bowel control issues. At BBI, our entire practice is focused on one thing: helping patients find relief from their bladder and bowel control problems. Our team of expert gynecologists and urologists is dedicated to helping both men and women find relief from these problems.

Lapovations is a medical device company creating a platform of innovative products that improve laparoscopy. Our flagship product AbGrab® is an FDA Class I, 510(k) exempt, patented, single-use medical device that uses existing O.R. wall suction to lift the abdominal wall. AbGrab® is a more reliable, less invasive, clinically tailored medical device that will revolutionize the most dangerous part of minimally invasive abdominal surgery.

• Greer Property Solutions’ purpose is to develop a profitable rental real estate portfolio by building, leasing, and selling high end residential rental properties in proximity to the University of Arkansas.• Profitable in each year of existence, GPS currently maintains a portfolio of over one million dollars in properties with plans for opportunistic growth in the future.• Responsibilities include actively managing leasing, selling, marketing, accounting, and maintenance.

6 Time President's Club Award Winner (Two Year Award – Top 5%)3 Time President's Club National Sales Representative of the Year (Two Year Award - #1 in U.S.)7 Time Star Achiever's Award Winner (One Year Award – Top 5%)1 Time Star Achiever's National Sales Representative of the Year (One Year Award - # 1 in U.S.)Rookie of the Year Award Winner (#1 Rookie in U.S.)

• TCBY (The Country's Best Yogurt) is an international franchise chain of frozen yogurt stores based in the United States and the largest retailer of soft-serve frozen yogurt with live active cultures.• NWA TCBY was the 2nd highest revenue non-airport TCBY store in the U.S. during first 12 months.• NWA TCBY generated 2.5x – 7x the revenue of local competitors and provided 20 – 25 jobs to the community.• Successfully negotiated the sale and transition of NWA TCBY to a long time customer in February 2015.

• Experience selling in primary care, podiatry, neurology, pain, rheumatology, orthopedic surgery, OB/GYN, urology, and endocrinology settings.• Promoted pharmaceuticals to medical professionals including physicians, pharmacists, and nurses. • Built and maintained relationships with key customers and accounts in order to increase sales potential and create new business opportunities. • Demonstrated a strong understanding of necessary disease states and possessed a solid ability to communicate technical, scientific, and product and disease management information to customers. • Consistently ranked by management as a top performer compared to peers.• Winner of numerous individual, LAT level, and district level performance awards.

• Tears for Life is a medical diagnostic equipment company that is developing an innovative, non-invasive, and convenient screening tool that can detect breast cancer in women’s tears.• Founded Tears for Life as a collaborative venture between a breast surgical oncologist at the University of Arkansas for Medical Sciences and MBA students at the University of Arkansas’ Walton College of Business.• Led Tears for Life to unprecedented success in numerous national and international business plan competitions that resulted in raising nearly $100,000 in cash prizes and significant publicity in the press.• Responsibilities included development of the business plan, company strategy, business model, market and competitive analysis, production, pricing, distribution, research and development, personnel, sales, and marketing strategies, assembling an outstanding management team and board of advisors, overseeing intellectual property protection, FDA clearance, negotiating coverage with commercial and government payors, and forging strong partnerships with organizations such as the Susan G Komen Foundation.• Led an attempt to gain additional funding for research and development through negotiations with several venture capital and angel investment firms as well as pursuing research grant applications.